Authors

  • Эшонова К.Г., Азизова Г.Дж.
    Author

References

1. Алиева Д.А., Тян Т.В., Нишанов Д.А. Пролиферативная активность эндометрия при аномальных маточных кровотечениях. Sammu.uz, 2022; №2.1: 25– 28.

2. Оразов М.Р., Хамошина М.Б., Муллина И.А., Артеменко Ю.С. Гиперплазия эндометрия – от патогенеза к эффективной терапии. Акушерство и гинекология: Новости. Мнения. Обучения. 2021; 3 (33).

3. ACOG Committee Opinion No. 800. The Use of Hysteroscopy for the Diagnosis and Treatment of Intrauterine Pathology. American College of Obstetricians and Gynecologists, 2019.

4. European Society of Gynaecological Oncology, European Society for Radiotherapy and Oncology, European Society of Pathology. Endometrial carcinoma: ESGO/ESTRO/ESP guidelines for management. Int J Gynecol Cancer. 2021;31(1):12–39.

5. Green, A., & Thompson, L. (2017). Endometrial Hyperplasia and Its Precursor Lesions: Clinical Implications for Diagnosis and Treatment. Obstetrics and Gynecology Clinics of North America, 44(3), 431-445

6. Galani A, et al. Endometrial hyperplasia: current insights into pathogenesis and risk factors. Cancers (Basel). 2025;18(1):148.

7. IARC. (2020). Global Cancer Statistics: Endometrial Cancer Overview. International Agency for Research on Cancer, Lyon.

8. Lasmar R.B., Dias R., Barrozo P.R. et al. Hysteroscopic evaluation. Best Practice & Research Clinical Obstetrics & Gynaecology. 2022.

9. National Cancer Institute (NCI). (2021). Endometrial Cancer: Risk Factors and Prevention. Retrieved from https://www.cancer.gov.

10. Pérez-Martín AR, Castro-Eguiluz D, Cetina-Pérez L, et al. Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention. Bosn J Basic Med Sci. 2022;22(4):499-510. Published 2022 Jul 29. doi:10.17305/bjbms.2021.6963

11. Royal College of Obstetricians and Gynaecologists. Management of Endometrial Hyperplasia. Green-top Guideline No. 67. London: RCOG; 2016 (updated 2022).

12. Smith, J., & Jones, P. (2020). Endometrial Hyperplasia and Its Role in Endometrial Cancer: A Review of Recent Studies. Journal of Gynecology, 55(4), 234- 245.

13. World Health Organization. WHO Classification of Tumours of Female Reproductive Organs. 5th ed. Lyon: IARC; 2020.

14. World Health Organization. Obesity and overweight. Geneva: WHO; 2023.

15. Wu Y, et al. Metabolic syndrome and insulin resistance in atypical endometrial hyperplasia and early endometrial cancer. BMC Cancer. 2025